Tumori Journal - TJ

The year's final issue of TJ is available at
journals.sagepub.com/toc/tmja/111...

🧐Find out about
✅Off-label cancer drugs
✅Clinical Trial Protocol
✅Lymphohaematopoietic malignancies
✅Radiotherapy for stage IV breast cancer
✅Pediatric palliative care
✅Liquid biopsy in prostate cancer
✅Case reports

#VirtualReality will lead to a reduction in distress, state and non-state anxiety symptoms, and depressive sympt.
Authors investigate the effects of exposure to VR (head-mounted display) on #anxiety and depressive symptoms in 35 aged 12–21 (#AYA) Pts.

journals.sagepub.com/doi/full/10....

#CanSky

#Sardinia| Authors reviewed the lymphohaematopoietic malignancies space-time coordinates and their association with potential environmental risk factors, evaluated their geographic correlation, and compared regional with nationwide time trends.

journals.sagepub.com/doi/full/10....

👉Choice of an endpoint can really change the way a treatment is administered or approved for use on patients. And in the future, we will see much more data on quality of life, and trials will probably also work on validating surrogate endpoints and biomarkers

Learn more omny.fm/shows/tumori...

🤔 What would happen if admissions for which a long hospital stay is recommended were planned from the moment patients are admitted?❓

🏥In a context of bed shortage and increasing healthcare costs, promoting actions that contain hospital stay is a priority.

journals.sagepub.com/share/PTRK6J...

#Surgery | Uniportal 3D VATS lobectomy demonstrates clear advantages over traditional 2D VATS lobectomy for #NSCLC patients by reducing perioperative pain, minimizing immune impairment, and preserving lung function.

journals.sagepub.com/share/ZEANWY...

#lungcancer

Thyroid cancer is the most common endocrine malignancy in the world including in #Turkey
👇
Etlik City Hospital, Ankara study | Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary #thyroidcancer❓

journals.sagepub.com/doi/full/10....

Find out how #liquidbiopsy is absolutely the new goal of #precisiononcology, capable of technologically and culturally revolutionising clinical practice, in this TJ Talks podcast with prof. Andrea Sartore Bianchi, leading expert in #colorectalcancer #CRCSM🩸🧪🧬

t.co/mm03GTJRT6

👉 FoundationOne®CDx provides an accurate assessment of ERBB2 copy number status and may be a cost-effective option in patients with metastatic cancer for whom #NGS testing is recommended.
Read more about this study at the link
journals.sagepub.com/share/UCJJ4G...

#CanSky

🗣️Scarcity of resources, insufficient authority: reform of Italian Ethics Committees aimed to simplify ethical oversight in #clinicalresearch
👇
Gaps remain in implementation and limited mandate of ECs excludes much ethically complex but unregulated research.

journals.sagepub.com/doi/10.1177/...

📢In TJ, just out the #AbstractBook of the Italian Association of Medical Oncology (AIOM) Congress 2025, 07-09 November 2025❗

🆓Browse through the 500 abstracts from the #AIOM2025 in the e-pub version here journals.sagepub.com/doi/epub/10....
@oncoalert.bsky.social #CanSky #OncoSky

🥊Researchers as gladiators in the “publish or perish” arena instead of appreciating their competence.

#OpenScience would help to reform this unhealthy system of evaluation (perhaps with #AI to support peer review🤖...).

Very impressive insights, thank you all❗️
#AIOM2025 and TJ - Round Table

📅 8 NOV | #Ethics in the evaluation of scientific research quality.
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀

📌XXVII AIOM Congress, Rome congresso.aiom.it

🗣️ This is the first prospective study conducted on patients with mRCC, previously treated with nivolumab plus metformin, which shows that the combination has limited clinical activity and does not improve progression-free survival.

journals.sagepub.com/share/ISAWAM...

#livercancer #HCC

This coming Saturday I'll be presenting about the Strain on Scientific Publishing at a round table organized by the Italian Oncology Association.

Very good to see that MDs are taking the crisis in scientific publications seriously and are looking for paths towards a saner system.

📅 8 NOV | #Ethics in the evaluation of scientific research quality.
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀

📌XXVII AIOM Congress, Rome congresso.aiom.it

@paolocrosetto.bsky.social

Effect of the IDH1 inhibitor combined with hypomethylating agents on acute myeloid #leukemia

journals.sagepub.com/share/TXZC4Y...

@LeukemiaRF @LLSCanada

#TJTalks #Podcast
🎧 Enjoy your listening!
omny.fm/shows/tumori...

Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

🧪 🔎 Clinicopathological characteristics and prognosis of #cervical #adenocarcinoma across diverse histological subtypes by Xiaowan Guo et al

journals.sagepub.com/share/ZUU92B...

🏥 Etlik City Hospital, Ankara, #Turkey➡️ Ongoing discussion: Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary thyroid cancer❓

journals.sagepub.com/share/GHVJPJ...

🗣️The system for evaluating the #Off-Label use of cancer drugs is highly fragmented, with consequences for #equity and clinical efficiency
👇
Addressing the problem requires coordinated action at institutional levels. Possibly involving medical #oncologists

journals.sagepub.com/doi/epub/10....

💥Integration of #LiquidBiopsy into a diagnostic algorithm
enables broader access to BRCA1/2 stratification and supports timely PARP inhibitor therapy

This #consensus aims to improve diagnostic consistency and clinical outcomes in #mCRPC management

journals.sagepub.com/share/HUFFX4...

#pcsm

🌟Tumori Journal Gastrointestinal Oncology Section is devoted to publish the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care.

No FEE to Publish in TJ!

Section Editors' bio-sketchs👇
tumorijournal.org/about-us/#ed...

"October is #BreastCancerAwarenessMonth, honouring millions of lives affected by breast cancer and reaffirm our global commitment to equitable access to care and improved survival for all." (WHO)
The #BreastCancer TJ Section Editors work on that 🎯

Visit link for SE's bio-sketchs t.co/arHPylNIcr

Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

EGFR mutations are predictive factors for cumulative incidence of brain metastasis🫁🧠
👇
Association between EGFR mutation types and incidence of brain metastases in postoperative patients with stage I–III #NSCLC - Zhang et al

journals.sagepub.com/doi/full/10....

#LCSM #lungcancer

💥Tumori Journal issue just out💥
Starting with an editorial by AIOM, the contents offer a broad overview of the most current and innovative topics in #oncology, covered by renowned researchers in the field.

Learn more journals.sagepub.com/toc/tmja/111...

#CanSky @oncoalert.bsky.social

💥This study contributes to the ongoing efforts to develop more personalized Normal Tissue Complication Probability (NTCP) models by incorporating patient-specific factors that may explain different responses to #radiotherapy dose.

journals.sagepub.com/share/A95GPU...

#RadOnc

💥Prof. Paolo Marchetti is the promoter of Trial of ROME clinical study and first author of #Nature groundbreaking paper on that.

In this #TJTalks about #PrecisionOncology and key aspects of the ROME study, he talks with Prof. Pruneri,
TJ EiC.

🎧 omny.fm/shows/tumori...

#CanSky #Oncosky

#CaseReport | Metastatic recurrence OR onset of a second primary malignancy❓

#PrecisionMedicine can offer valuable support in diagnosis👇

#Breastcancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report

journals.sagepub.com/share/U56Y6Z...

#cansky #oncosky

💡 Do you have groundbreaking research to publish, or a topic on the latest trends in oncology for a #TJTalks #podcast❓

Contact us tumorijournal.org/contact-us/

✍ Fill out the form with a brief presentation of the topic you suggest. We will be happy to receive your valuable contribution 😀